FIELD: medicine.
SUBSTANCE: injection of platelet-rich of autoplasma in an amount of 2 ml at the first injection into the aseptic necrosis zone and/or the cystic cavity located in the subchondral zone, using a needle, via the medial condyle of the tibia and/or the medial condyle of the femur, 2-3 times per treatment course with an interval of 7-10 days. For each subsequent injection, the volume of platelet-rich autoplasm is 2 times greater than for the previous injection.
EFFECT: method allows to ensure low invasiveness of intervention, to shorten the pain relief period, to quickly restore the structure of the affected bone area, does not require the patient to stay in hospital, significantly improves the results of treatment of patients with this pathology, shortens the rehabilitation period and improves the quality of life.
4 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING OSTEOARTHROSIS OF KNEE JOINT | 2019 |
|
RU2703821C1 |
METHOD OF TREATING OSGOOD-SCHLATTER SYNDROME | 2015 |
|
RU2599202C1 |
METHOD FOR TREATMENT OF THE INITIAL STAGES OF ASEPTIC NECROSIS OF THE FEMORAL HEAD AND/OR NECK | 2021 |
|
RU2763982C1 |
METHOD OF TREATMENT OF OSTEOARTHROSIS OF ANIMALS | 2014 |
|
RU2565413C1 |
METHOD OF TREATING OSTEOARTHROSIS OF KNEE | 2010 |
|
RU2455028C1 |
METHOD FOR TREATING OSTEOARTHROSIS OF KNEE JOINT | 2017 |
|
RU2688176C2 |
METHOD FOR TREATMENT OF INITIAL ASEPTIC OSTEONECROSIS OF MIDDLE AND POSTERIOR PARTS OF FOOT DUE TO PATHOLOGICAL FUNCTIONAL RESTRUCTURING OF BONE TISSUE | 2019 |
|
RU2758831C2 |
METHOD FOR SURGICAL MANAGEMENT OF MEDIAL OSTEOARTHRITIS OF KNEE JOINT | 2023 |
|
RU2816801C1 |
METHOD FOR PREVENTION OF COMPLICATIONS IN PATIENTS AFTER PERFORMING ARTHROSCOPIC OPERATIONS ON KNEE JOINT USING AUTOLOGOUS THROMBOCYTES | 2024 |
|
RU2837466C1 |
METHOD OF TREATING FEMORAL HEAD AVASCULAR NECROSIS AT STAGE 2 OF AVASCULAR NECROSIS BY ARCO | 2022 |
|
RU2815166C1 |
Authors
Dates
2017-05-25—Published
2015-12-22—Filed